Semiconductor designer Advanced Micro Devices Inc (AMD) said on Tuesday it would buy Xilinx Inc in a $35 billion all-stock deal, intensifying its battle with Intel Corp in the data center chip market.
Targeted drug delivery is a powerful and promising area of medicine. Therapies that pinpoint the exact areas of the body ...